ANAB Financial Statements

Balance sheet, income statement, cash flow, and dividends for Anaptysbio Inc (ANAB).


$402.88M Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

ANAB Market Cap. (MRY)


ANAB Shares Outstanding (MRY)


ANAB Assets (MRY)


Total Assets

$483.83M

Total Liabilities

$412.97M

Total Investments

$297.76M

ANAB Income (MRY)


Revenue

$91.28M

Net Income

-$145.23M

Operating Expense

$206.23M

ANAB Cash Flow (MRY)


CF Operations

-$135.34M

CF Investing

$95.40M

CF Financing

$127.05M

ANAB Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ANAB Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$483,834,000 (6.95%)

$452,389,000 (-25.88%)

$610,383,000 (-5.08%)

$643,070,000 (54.38%)

Assets Current

$431,876,000 (6.16%)

$406,835,000 (-9.03%)

$447,205,000 (-19.26%)

$553,876,000 (39.67%)

Assets Non-Current

$51,958,000 (14.06%)

$45,554,000 (-72.08%)

$163,178,000 (82.95%)

$89,194,000 (346.17%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$70,868,000 (-19.56%)

$88,103,000 (-66.39%)

$262,103,000 (-26.46%)

$356,428,000 (-10.16%)

Property Plant & Equipment Net

$16,232,000 (-11.16%)

$18,272,000 (-8.58%)

$19,987,000 (-8.49%)

$21,841,000 (926.85%)

Cash & Equivalents

$123,080,000 (242.22%)

$35,965,000 (-49.56%)

$71,308,000 (-85.62%)

$495,729,000 (97.93%)

Accumulated Other Comprehensive Income

$305,000 (138.27%)

-$797,000 (84.81%)

-$5,246,000 (-1143.13%)

-$422,000 (-10450.00%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$297,763,000 (-22.04%)

$381,965,000 (-25.52%)

$512,868,000 (329.30%)

$119,465,000 (-25.71%)

Investments Current

$262,293,000 (-26.10%)

$354,939,000 (-4.05%)

$369,933,000 (606.41%)

$52,368,000 (-63.43%)

Investments Non-Current

$35,470,000 (31.24%)

$27,026,000 (-81.09%)

$142,935,000 (113.03%)

$67,097,000 (281.10%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$40,765,000 (495.02%)

$6,851,000 (382.80%)

$1,419,000 (61.99%)

$876,000 (0%)

Trade & Non-Trade Payables

$4,002,000 (-14.81%)

$4,698,000 (68.75%)

$2,784,000 (59.91%)

$1,741,000 (-58.71%)

Accumulated Retained Earnings (Deficit)

-$759,327,000 (-23.65%)

-$614,096,000 (-36.32%)

-$450,477,000 (-40.01%)

-$321,753,000 (-21.90%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$16,037,000 (-9.98%)

$17,814,000 (-8.41%)

$19,450,000 (-7.18%)

$20,955,000 (6027.19%)

Debt Current

$1,925,000 (8.33%)

$1,777,000 (8.55%)

$1,637,000 (8.77%)

$1,505,000 (340.06%)

Debt Non-Current

$14,112,000 (-12.00%)

$16,037,000 (-9.97%)

$17,813,000 (-8.42%)

$19,450,000 (0%)

Total Liabilities

$412,966,000 (13.36%)

$364,286,000 (4.60%)

$348,280,000 (21.50%)

$286,642,000 (1346.15%)

Liabilities Current

$45,428,000 (21.33%)

$37,442,000 (43.71%)

$26,054,000 (61.84%)

$16,099,000 (-18.78%)

Liabilities Non-Current

$367,538,000 (12.45%)

$326,844,000 (1.43%)

$322,226,000 (19.10%)

$270,543,000 (0%)

ANAB Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$91,280,000 (432.03%)

$17,157,000 (66.78%)

$10,287,000 (-83.72%)

$63,175,000 (-15.77%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$42,389,000 (1.06%)

$41,946,000 (14.47%)

$36,643,000 (70.49%)

$21,493,000 (14.00%)

Research & Development Expense

$163,840,000 (23.86%)

$132,283,000 (48.97%)

$88,798,000 (-9.85%)

$98,496,000 (23.08%)

Operating Expenses

$206,229,000 (13.58%)

$181,568,000 (44.74%)

$125,441,000 (4.54%)

$119,989,000 (21.35%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$3,000 (175.00%)

-$4,000 (-116.67%)

$24,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$145,231,000 (11.24%)

-$163,619,000 (-27.11%)

-$128,724,000 (-122.72%)

-$57,796,000 (-189.98%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$145,231,000 (11.24%)

-$163,619,000 (-27.11%)

-$128,724,000 (-122.72%)

-$57,796,000 (-189.98%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$145,231,000 (11.24%)

-$163,619,000 (-27.11%)

-$128,724,000 (-122.72%)

-$57,796,000 (-189.98%)

Weighted Average Shares

$28,382,000 (5.42%)

$26,924,000 (-4.41%)

$28,165,000 (2.68%)

$27,431,000 (0.47%)

Weighted Average Shares Diluted

$28,382,000 (5.42%)

$26,924,000 (-4.41%)

$28,165,000 (2.68%)

$27,431,000 (0.47%)

Earning Before Interest & Taxes (EBIT)

-$145,228,000 (11.24%)

-$163,623,000 (-27.14%)

-$128,700,000 (-122.68%)

-$57,796,000 (-189.98%)

Gross Profit

$91,280,000 (432.03%)

$17,157,000 (66.78%)

$10,287,000 (-83.72%)

$63,175,000 (-15.77%)

Operating Income

-$114,949,000 (30.08%)

-$164,411,000 (-42.77%)

-$115,154,000 (-102.69%)

-$56,814,000 (-137.92%)

ANAB Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$95,398,000 (-34.10%)

$144,754,000 (136.66%)

-$394,845,000 (-1116.72%)

$38,835,000 (-58.89%)

Net Cash Flow from Financing

$127,054,000 (314.27%)

-$59,297,000 (-234.71%)

$44,017,000 (-82.55%)

$252,298,000 (28802.84%)

Net Cash Flow from Operations

-$135,337,000 (-12.03%)

-$120,800,000 (-64.15%)

-$73,593,000 (-60.26%)

-$45,920,000 (-224.36%)

Net Cash Flow / Change in Cash & Cash Equivalents

$87,115,000 (346.48%)

-$35,343,000 (91.67%)

-$424,421,000 (-273.08%)

$245,213,000 (208.68%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$95,756,000 (-34.22%)

$145,561,000 (136.90%)

-$394,487,000 (-1081.65%)

$40,186,000 (-57.72%)

Capital Expenditure

-$358,000 (55.64%)

-$807,000 (-125.42%)

-$358,000 (73.50%)

-$1,351,000 (-137.43%)

Issuance (Repayment) of Debt Securities

-$15,233,000 (-29.91%)

-$11,726,000 (-373.97%)

-$2,474,000 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$92,882,000 (295.43%)

-$47,528,000 (-501.86%)

$11,827,000 (363.26%)

$2,553,000 (414.72%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$34,048,000 (2.54%)

$33,205,000 (21.38%)

$27,356,000 (78.25%)

$15,347,000 (33.46%)

Depreciation Amortization & Accretion

$2,397,000 (0.88%)

$2,376,000 (1.76%)

$2,335,000 (11.72%)

$2,090,000 (29.25%)

ANAB Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-159.10% (83.32%)

-953.70% (23.78%)

-1251.30% (-1267.54%)

-91.50% (-243.98%)

EBITDA Margin

-156.50% (83.35%)

-939.80% (23.49%)

-1228.40% (-1292.74%)

-88.20% (-261.48%)

Return on Average Equity (ROAE)

-272.90% (-128.56%)

-119.40% (-172.60%)

-43.80% (-186.27%)

-15.30% (-194.23%)

Return on Average Assets (ROAA)

-32.10% (1.53%)

-32.60% (-55.98%)

-20.90% (-71.31%)

-12.20% (-148.98%)

Return on Sales (ROS)

-159.10% (83.32%)

-953.70% (23.77%)

-1251.10% (-1267.32%)

-91.50% (-243.98%)

Return on Invested Capital (ROIC)

-45.60% (-20.95%)

-37.70% (-52.63%)

-24.70% (53.83%)

-53.50% (-365.22%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.59 (26.60%)

-3.52 (48.05%)

-6.78 (58.83%)

-16.47 (44.08%)

Price to Sales Ratio (P/S)

4.12 (-87.75%)

33.61 (-60.38%)

84.85 (462.32%)

15.09 (92.78%)

Price to Book Ratio (P/B)

5.68 (-12.01%)

6.46 (92.18%)

3.36 (25.35%)

2.68 (80.97%)

Debt to Equity Ratio (D/E)

5.83 (40.92%)

4.13 (211.14%)

1.33 (65.30%)

0.8 (1508.00%)

Earnings Per Share (EPS)

-5.12 (15.79%)

-6.08 (-33.04%)

-4.57 (-116.59%)

-2.11 (-189.04%)

Sales Per Share (SPS)

3.22 (404.87%)

0.64 (74.52%)

0.36 (-84.15%)

2.3 (-16.16%)

Free Cash Flow Per Share (FCFPS)

-4.78 (-5.84%)

-4.52 (-72.01%)

-2.63 (-52.41%)

-1.72 (-219.67%)

Book Value Per Share (BVPS)

2.5 (-23.69%)

3.27 (-64.84%)

9.31 (-28.38%)

12.99 (-10.58%)

Tangible Assets Book Value Per Share (TABVPS)

17.05 (1.46%)

16.8 (-22.47%)

21.67 (-7.55%)

23.44 (53.65%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (33.33%)

-3 (57.14%)

-7 (36.36%)

-11 (42.11%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.59 (54.17%)

-3.48 (47.79%)

-6.67 (42.02%)

-11.5 (44.41%)

Asset Turnover

0.2 (494.12%)

0.03 (100.00%)

0.02 (-87.31%)

0.13 (-27.17%)

Current Ratio

9.51 (-12.51%)

10.87 (-36.70%)

17.16 (-50.11%)

34.4 (71.96%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$135,695,000 (-11.58%)

-$121,607,000 (-64.44%)

-$73,951,000 (-56.44%)

-$47,271,000 (-221.00%)

Enterprise Value (EV)

$227,788,750 (-59.41%)

$561,179,313 (-33.38%)

$842,388,276 (31.53%)

$640,447,290 (69.09%)

Earnings Before Tax (EBT)

-$145,228,000 (11.24%)

-$163,623,000 (-27.14%)

-$128,700,000 (-122.68%)

-$57,796,000 (-189.98%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$142,831,000 (11.42%)

-$161,247,000 (-27.60%)

-$126,365,000 (-126.84%)

-$55,706,000 (-204.17%)

Invested Capital

$331,363,000 (-16.49%)

$396,796,000 (-25.48%)

$532,471,000 (249.86%)

$152,197,000 (3.81%)

Working Capital

$386,448,000 (4.62%)

$369,393,000 (-12.29%)

$421,151,000 (-21.69%)

$537,777,000 (42.74%)

Tangible Asset Value

$483,834,000 (6.95%)

$452,389,000 (-25.88%)

$610,383,000 (-5.08%)

$643,070,000 (54.38%)

Market Capitalization

$402,875,750 (-29.23%)

$569,240,313 (-35.39%)

$881,096,276 (-7.83%)

$955,900,290 (62.57%)

Average Equity

$53,223,000 (-61.15%)

$137,007,250 (-53.35%)

$293,693,750 (-22.08%)

$376,927,500 (-2.03%)

Average Assets

$452,615,750 (-9.86%)

$502,151,750 (-18.28%)

$614,476,250 (30.02%)

$472,598,000 (16.17%)

Invested Capital Average

$318,781,250 (-26.56%)

$434,073,000 (-16.66%)

$520,818,750 (381.86%)

$108,085,250 (-37.67%)

Shares

30,428,682 (14.50%)

26,575,178 (-6.53%)

28,431,632 (3.36%)

27,507,922 (0.59%)